Navigation Links
CSHL scientist recognized for accelerating cancer gene research
Date:12/10/2007

Dr. Lars Zender, a senior clinical postdoctoral fellow at Cold Spring Harbor Laboratory (CSHL) was recently awarded a $40,000 grant for his seminal contributions in the field of cancer biology and epigenomics. The grant, presented at the second annual Cracking the Code with the Bear Research Symposium, will fund Zenders ongoing cancer research.

At CSHL, Zender studies the genetics and biology of hepatocellular carcinoma, a primary cancer of the liver, and the third leading cause of cancer death worldwide. For the last four years, he has partnered with various CSHL research teams to develop a unique mouse model for liver cancer research, which enabled him to identify new tumor suppressor genes in liver cancer.

Lars has done an outstanding job integrating work with mouse cancer models, cancer genomics, and RNA interference to identify genes that contribute to human cancer, said Scott Lowe, Ph.D., deputy director of the CSHL Cancer Center and Howard Hughes Medical Institute investigator. His approach shifts the paradigm. The genes he has identified suggest new approaches for treating cancer. This award is a wonderful recognition of both his current impact and future potential.

The symposium, sponsored by the Bear Necessities Pediatric Cancer Foundation in Chicago, IL, provides a forum for ten exceptional post-doctoral scientists from prominent institutions in the US and Canada to present their current cancer research. The Bear Foundation selected the presenters based on nominations received from mentors and senior leaders in their field of research. In addition to Zender, two other CSHL postdoctoral fellows presented their research. Dr. Danielle Irvine spoke about her work on the role of RNAi-mediated epigenetic genome regulation, and Dr. Julius Brennecke presented his work on piRNAs in the Drosophila germline.

To have three of the ten qualifying participants at the symposium representing Cold Spring Harbor Laboratory is impressive, David L. Spector, Ph.D., CSHL research director said. CSHLs groundbreaking research is largely due to our ability to attract and nurture the best young scientific minds.

CSHL is probably the most interactive institution that I know. In my project I was able to combine different state of the art technologies, taking our research to a new level, Zender said. The combination of cutting edge technologies from different CSHL labs allowed me to address complex biological questions in a highly efficient and effective way. Zenders research was made possible by multidisciplinary collaboration across several CSHL laboratories. Zender leveraged ROMA, a high resolution genome scanning technology pioneered by CSHL to identify and validate two new oncogenes genes for liver cancer.

With the grant, Dr. Zender will be able to continue his project on in vivo RNAi screening to identify new tumor suppressor genes in liver cancer. In particular the grant will enable the project to be conducted with the use of even more powerful next generation sequencing technologies.


'/>"/>

Contact: Jim Bono
bono@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Caduceus International Publishing (CIP), a ... a new online course entitled Personal & Community Health for the ... for achieving optimal well-being and teaches students how to apply them in their ...
(Date:6/20/2017)... ... June 20, 2017 , ... Kenneth Mayer, MD, has been appointed ... , Dr. Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more ... Director of Fenway Health and Co-Chair of The Fenway Institute, a member ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... AMC ... continued expansion and success in the clinical trials market. Similar to its approach in ... record in the clinical trials marketplace by proving the value of eVisits to support ...
(Date:6/20/2017)... Ohio (PRWEB) , ... June 20, 2017 , ... ... gum disease in Cincinnati, OH for leading-edge care, whether or not ... in laser dentistry. Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and ...
(Date:6/20/2017)... PA (PRWEB) , ... June 20, 2017 , ... ... at Allegheny Health Network’s (AHN) Jefferson Hospital is providing physicians with advanced capabilities ... scanner provides higher-resolution images than traditional MRIs, enabling doctors to get a more ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 6, 2017  Diplomat Specialty Infusion Group, a brand of Diplomat ... its Iowa location. The ... now features an ISO 7 cleanroom—the standard needed to compound intravenous ... low level of pollutants. "Our ... and better serve our Iowa patients," said ...
(Date:6/1/2017)... Nutriceutical Holdings (NH), parent company of Physician ... KD Pharma Group have decided to join forces through ... Group. KD Pharma Group will become the largest shareholder ... entire company. "We believe we have found ... growing the NH companies by providing us with supply ...
(Date:5/26/2017)... International plc (NASDAQ: ENDP ) announced today that ... Company in a fireside chat at Goldman Sachs, 38 th ... at 10:40 a.m. PT / 1:40 p.m. ET. The conference ... Palos Verdes, CA. A live webcast ... the Company,s website at http://www.endo.com/investors/overview . Participants should allow ...
Breaking Medicine Technology: